These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38000027)
1. Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous Kim J; Kim S; Lee SY; Jo BK; Oh JY; Kwon EJ; Kim KT; Adpaikar AA; Kim EJ; Jung HS; Kim HR; Roe JS; Hong CP; Kim JK; Koo BK; Cha HJ Sci Adv; 2023 Nov; 9(47):eadi8454. PubMed ID: 38000027 [TBL] [Abstract][Full Text] [Related]
2. Roadmap of the Early Events of Guallar D Cell Reprogram; 2023 Feb; 25(1):7-8. PubMed ID: 36695734 [TBL] [Abstract][Full Text] [Related]
3. Deciphering the roadmap of in vivo reprogramming toward pluripotency. Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281 [TBL] [Abstract][Full Text] [Related]
4. A Versatile In Vivo System to Study Myc in Cell Reprogramming. Senís E; Mosteiro L; Grimm D; Abad M Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296 [TBL] [Abstract][Full Text] [Related]
5. Regeneration and reprogramming compared. Christen B; Robles V; Raya M; Paramonov I; Izpisúa Belmonte JC BMC Biol; 2010 Jan; 8():5. PubMed ID: 20089153 [TBL] [Abstract][Full Text] [Related]
6. Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming. Hu K Cells; 2020 Nov; 9(11):. PubMed ID: 33203179 [TBL] [Abstract][Full Text] [Related]
7. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells. Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202 [TBL] [Abstract][Full Text] [Related]
8. Distinguishing Between Endodermal and Pluripotent Stem Cell Lines During Somatic Cell Reprogramming. Moauro A; Ralston A Methods Mol Biol; 2022; 2429():41-55. PubMed ID: 35507154 [TBL] [Abstract][Full Text] [Related]
9. In vivo reprogramming leads to premature death linked to hepatic and intestinal failure. Parras A; Vílchez-Acosta A; Desdín-Micó G; Picó S; Mrabti C; Montenegro-Borbolla E; Maroun CY; Haghani A; Brooke R; Del Carmen Maza M; Rechsteiner C; Battiston F; Branchina C; Perez K; Horvath S; Bertelli C; Sempoux C; Ocampo A Nat Aging; 2023 Dec; 3(12):1509-1520. PubMed ID: 38012287 [TBL] [Abstract][Full Text] [Related]
10. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells. Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429 [TBL] [Abstract][Full Text] [Related]
11. Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer. Hong L; Hong S; Zhang X Medicine (Baltimore); 2023 Dec; 102(48):e36433. PubMed ID: 38050242 [TBL] [Abstract][Full Text] [Related]
12. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Mosteiro L; Pantoja C; Alcazar N; Marión RM; Chondronasiou D; Rovira M; Fernandez-Marcos PJ; Muñoz-Martin M; Blanco-Aparicio C; Pastor J; Gómez-López G; De Martino A; Blasco MA; Abad M; Serrano M Science; 2016 Nov; 354(6315):. PubMed ID: 27884981 [TBL] [Abstract][Full Text] [Related]
13. Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo. Doeser MC; Schöler HR; Wu G Stem Cells; 2018 Aug; 36(8):1216-1225. PubMed ID: 29761584 [TBL] [Abstract][Full Text] [Related]
14. In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche. Wang C; Rabadan Ros R; Martinez-Redondo P; Ma Z; Shi L; Xue Y; Guillen-Guillen I; Huang L; Hishida T; Liao HK; Nuñez Delicado E; Rodriguez Esteban C; Guillen-Garcia P; Reddy P; Izpisua Belmonte JC Nat Commun; 2021 May; 12(1):3094. PubMed ID: 34035273 [TBL] [Abstract][Full Text] [Related]
15. Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation. Lehmann M; Canatelli-Mallat M; Chiavellini P; Cónsole GM; Gallardo MD; Goya RG Curr Gene Ther; 2019; 19(4):248-254. PubMed ID: 31475896 [TBL] [Abstract][Full Text] [Related]
16. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells. Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880 [TBL] [Abstract][Full Text] [Related]